Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of vilanterol in children with persistent uncontrolled asthma on inhaled corticosteroids
2011-003337-34Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of vilanterol in asthma (3 arms), sponsored by GSK. Primary endpoint: Mean change from baseline in daily pre-dose evening peak expiratory flow. Started Nov 2011; status: completed.
02
Drugs
vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-003337-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003337-34.